Welcome to article directory Lawsuit Feed. Here You can find interesting and useful information on most popular themes.

There are 448 published articles and 245 registered authors in our article directory.

Recent Articles

Actos Bladder Cancer Lawsuits Notice

By admin | Published January 27, 2012

Actos Bladder Cancer Lawsuits : The incidence of bladder cancer has risen over the past 20 years. Currently, around 54 500 new cases of bladder cancer are diagnosed in the USA each year, and 15 000 cases in the UK. Bladder cancer is the fourth most common cancer in men in the USA and the tenth most common in women. It is one of the most frequent causes of cancer death, accounting for about 10 000 deaths annually in the USA and 5000 in the UK.

More information on Actos Bladder Cancer Lawsuits

The incidence of bladder cancer varies among different patient groups. For example, there is a 3:1 male-to-female ratio, though the prevalence among women appears to be rising.

The incidence is higher in elderly populations, with a median age at presentation of 60-65 years. No evidence exists for a familial or inherited pattern among any patient group, although occasional family clusters have been recorded. In black people the incidence is lower than in white people; in Asian races it appears to be intermediate. The lifetime risk of developing bladder cancer is:

  • 2.8% for white men
  • 0.9% for black men
  • 1.0% for white women
  • 0.6% for black women.

Information from other sources on Actos Bladder Cancer Lawsuits

Five-year survival for both black and white people during the period 1986-92 (60% and 82%, respectively) was significantly better than the equivalent rates for 1974-76 (47% and 74%, respectively; p < 0.05). It is not really known why there are substantial ethnic differences in incidence and prognosis, although putative factors include differences in diet and nutritional status, differences in gene expression (especially of enzymes that may metabolize carcinogens) and differential access to healthcare.

Our use of the term or terms Actos Bladder Cancer Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on (keyword) visit our site often.

Actos Bladder Cancer Lawsuits

Posted in Uncategorized | Tagged |

Actos Warning News

By admin | Published January 27, 2012

Actos Warning : In general, patients with severe mood disturbances (e.g., panic attacks; suicide ideation) require immediate psychological evaluation and treatment to stabilize their acute condition before CAM therapies may be considered. For most patients with mild to moderate anxiety and mood disturbances, CAM therapies are a useful adjunct to conventional treatments for managing psychological distress. Techniques such as mind-body interventions, acupuncture, and music therapy are generally safe when performed by qualified, experienced practitioners and can help cancer patients better cope with feelings of anxiety, fear, hopelessness, and depression. Although some herbs and dietary supplements (e.g., Kava Kava; St. John’s Wort,- Passionflower) have been reported to relieve anxiety and mood disturbances, some experts have discouraged the use of these products in cancer patients because they may interfere with drugs used to treat cancer (chemotherapeutic agents) and/or other medications that patients may be taking. Patients should discuss the risks and benefits of using any herbal medications/dietary supplements with their oncologist before taking any of these products, particularly if they are undergoing chemotherapy, radiation therapy, or surgery

More information on Actos Warning

Pain is a relatively common symptom that is experienced by many cancer patients. In recent years, increased awareness about this problem has led to important advances in the management of patients with cancer-related pain. In fact, today most major cancer centers in the United States have established pain management clinics, usually located within the Anesthesiology department of a hospital, that specialize in helping patients to better control their cancer-related pain.

Information from other sources on Actos Warning

Most often, the source of cancer-related pain is the tumor itself. This can occur when a tumor spreads and invades other tissues or organs of the body; when a tumor compresses a nearby nerve or the spinal cord; or when a tumor causes intestinal obstruction. Cancer-related pain may also be caused by some procedures that are used for the diagnosis and treatment of cancer. Examples include tissue biopsy; placement of a central line catheter; bone marrow aspiration; and spinal tap.

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

Actos Warning

Posted in Uncategorized | Tagged |

Actos Bladder Cancer Top News

By admin | Published January 25, 2012

Actos Bladder Cancer : You probably have already figured out that cystectomy is a surgical procedure performed under anesthesia in a hospital setting. Depending on what kind of bladder reconstruction you have, you may stay in the hospital anywhere from 5 to 14 days. The descriptions included here of medical procedures and treat­ments are of a general nature; your own experience may differ from what is discussed here. With cystectomy, an incision is made through the abdominal wall, so you can expect some mild discomfort at the incision site. The inci­sion will be covered, and you probably won’t be able to shower or get the incision wet for about a week to 10 days. You may have a drain from the incision, a flexible tube with a hollow bulb on the end that you will remove, empty, flush out, and reattach as needed. Your doc­tor will remove the drain (it’s painless) and any stitches or staples in a follow-up visit 10 days or so after your surgery.

Some possible complications include infection, bleeding, blood clots, or intestinal obstruction. You may experience some difficulties with your urinary diversion system. You’ll be asked to wait for a few weeks after surgery before you drive, and your doctors are likely to want you to refrain for several weeks from doing anything that strains the abdominal area, such as pushing and pulling a vacuum cleaner or lifting heavy objects or engaging in any other activity that might damage the scar or even pull the scar tissue apart, thereby risking the formation of a hernia. A her­nia occurs when your surgical scar pulls apart under the skin and allows a part of the underlying bowel to poke forward, creating a noticeable lump. It can interfere with the functioning of your bowel and therefore needs to be fixed, either with an external truss or sup­port, or possibly through another surgical operation.

It’s smarter just to avoid the risk in the first place by not stressing the scar soon after surgery. This is the time to take it easy and when possible allow friends or family to pamper you by helping with chores and housework. Just don’t get too used to having someone bring you the morning newspaper and a cup of coffeel Generally it’s a good idea to talk about this with your doctor and find out what you can and cannot safely do.There are some negative consequences of cystectomy that you should discuss thoroughly with your medical team. As mentioned above, there may be changes in urinary function. These will depend largely on the type of surgery and on whether an artificial bladder has been created. Sometimes while the abdominal tissues are healing after surgery there will be a period of irregular bowel function, during which you will unexpectedly have to deal with diarrhea or constipation.

More information on Actos Bladder Cancer

Occasionally there will be some swelling in one or both legs, due either to fluid retention or the formation of scar tissue around the lymph vessels that drain the legs. Often there will be the presence of an asymptomatic, low-grade chronic urinary tract infection that will be identified upon routine testing. This occurs because of the changed pattern of emptying the new bladder. Usually it causes no problems and doesn’t require active treatment with antibiotics. Other issues also arise. Worries about possible changes in sexual function are common, and very normal. Sexual function often does change after cystectomy That doesn’t mean you can’t have an active, playful, pleasurable sex life with your partner. It does mean that you’ll probably explore innovative strategies as you seek comfortable ways to experience fulfillment.

Men experience more extreme changes in sexual function after surgeiy than women do. Around half the men who undergo cystec­tomy experience nerve damage that leaves them impotent afterwards, a serious lifestyle change that is not only physical but emotional, requiring much thoughtful discussion between you, your partner, and your medical team both before surgery and after. If you are able to have an erection after surgery, you won’t be able to ejaculate, because ’without a prostate, your body is no longer able to produce semen. You’ll find that the physical sensation of orgasm is different from what you are accustomed to. It’s not unpleasant; just different. In general, the younger you are at the time of surgery, the more likely you will be to have erections or to regain over time the capability of having them. There are surgical procedures, such as penile inserts, that can help make sexual activity possible.

For women, a cystectomy includes the removal of the uterus and part of the vaginal wall. What does that mean for you? Well, for one thing, your vagina may be narrower as a result of the surgery. Usually it’s possible to continue to have intercourse, although sometimes there can be some pain involved. Be sure to talk to your doctor if you do experience pain as there are methods of reducing this.

Information from other sources on Actos Bladder Cancer

Most women diagnosed with bladder cancer already have experienced menopause. (Typically, women who receive diagnoses of bladder cancer are older.) For younger women, that may not be the case. The removal of the uterus and pos­sibly of other female organs near the Most women diagnosed bladder brings an abrupt end to the child- with bladder cancer bearing years. It may also set off typical already have experienced menopausal symptoms such as hot flash- menopause. (Typically, es or mood swings if the ovaries have women who receive been removed at surgery (removal of diagnoses of bladder ovaries is unusual). If you find yourself cancer are older.) feeling depressed or blue or uncomfort­able from hot flashes, talk to your doctor. You don’t have to feel that way; there are options available for you to consider.

As is recommended for men, talking with your partner and your medical team about the physical and emotional changes that you may experience after a cystectomy is an important part of the process, one that deserves as much consideration as the more immediate decisions about which treatment options you want to pursue. Keep in mind that cystectomy is a life-preserving weapon against invasive cancer. That doesn’t mean you can’t or shouldn’t consider the possibility of impotence or altered sexual function with your partner, or the inability to carry a child. It does offer the hope that you can celebrate many more years of healthy, loving life with your friends and family. That’s an important thing to remember at a time when life may seem to be serving you big helpings of despair.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Actos Side Effects Info

By admin | Published January 25, 2012

Actos Side Effects : More information on Actos Side Effects

After the initial shock of being given a new diagnosis of cancer, a flood of emotions follow with fear and anxiety being foremost. Questions fill your mind:

How serious is it?

Can 1 be cured?

Am I going to die?

Will I suffer?

What treatments are available?

Can 1 do anything to improve my odds?

What side effects will occur from the treatments?

Will I lose time from work?

Will my insurance cover the cost?

Will I be disfigured?

Will my spouse and family be supportive?

Do 1 have a good doctor?

Bladder cancer, or any serious potentially life threatening illness is generally alien to most individuals. Suddenly, lives are changed and a new reality must be dealt with. Becoming a “patient” or worse “a cancer patient” is not only threatening, but a dreaded proposition. Cancer patients are not happy with the loss of autonomy, the invasion of privacy, the discomfort inflicted upon them and the demands on their time and quality of life. As a patient, being thrust into this altered identity, it is essential to seek out the information you need. Having a fundamental base of knowledge is a must when facing the issues and treatment decisions which lie ahead. In the following pages, together we will explore bladder cancer, a disease which is totally foreign to most of us until the diagnosis is made. I have chosen to present the information in a question and answer format, written in a conversational tone, as if I were having an extended consultation with one of my patients. The questions are typical of what individuals have asked over the years. 1 have covered the key issues and decisions the individual with bladder cancer may face. The answers are to the point and cover the essentials required to make an informed decision for most individuals. For others, a more detailed resource may be required. For helpful sources of additional information see the Appendix.

Each individual’s situation is unique. Decisions on treatment may be modified based on the patient’s preferences and values and altered by other considerations such as age and coexisting conditions. By becoming an individual knowledgeable of bladder cancer, you will be prepared to fully partner with your physician for your best possible outcome. To your companions and family members, this book will serve to answer the many questions and doubts that may arise. Having your loved ones informed and supportive is a big plus for the individual facing this new challenge.

The book is written in a logical sequence starting with finding a qualified urologist to the basics on bladder cancer, its assessment and treatment. At the end of the book, you will find chapters on complementary medicine, advance care planning, and hospice care. The book can be read in sequence or each chapter can serve as a resource covering the basics of the topic. It is my hope this book will help clarify the many issues and options individuals must face with bladder cancer. For family members, significant others and concerned friends, this resource should help improve your understanding and thus your ability to assist your loved one.

 

Information from other sources on Actos Side Effects

Understanding bladder cancer is a tremendous first step that will assist you in your treatment. Having a qualified urologist administer the actual treatments and care for you is essential for the best possible outcome. In the following chapter, we will explore what you need to know to assure you have the right urologist.

BESIDES LEARNING ABOUT MY DISEASE, WHAT IS MY MOST IMPORTANT FIRST STEP?

Make sure you have an excellent urologist supervising your care. A urologist is a surgical specialist trained to care for conditions involving the male and female urinary tracts and the male reproductive system. The bladder is part of the urinary system, and a urologist is trained to care for problems involving it, including cancer.

IS IT IMPORTANT TO HAVE A BOARD CERTIFIED UROLOGIST?

A urologist board certified by The American Board of Urology has gone through an accredited urology training program (generally a four year program), following two years of internship and residency in surgery after four years of medical school. The urologist must be in practice after training and provide a detailed list of surgeries, including complications, over a twelve month period. The doctor will then take a two day oral and written test covering a wide spectrum of urology. If he passes, he is certified for a period of ten years. At the end of the ten year period, he must recertify to maintain his board status. Recertification entails a three month surgical and procedure log and a written test as well as reference letters from those in a position to judge the practicing urologist’s work. Any malpractice or judgments are also reviewed. Although being board certified does not guarantee you have an excellent urologist, it demonstrates that he has the fund of knowledge to practice urology competently. Even though board certification is voluntary, in today’s competitive environment more and more hospitals and insurance plans are requiring their specialists to be certified.

HOW CAN I TELL IF MY UROLOGIST IS BOARD CERTIFIED?

The urologist has worked hard to obtain board certification. The certificate from The American Board of Urology is often displayed openly in his office. If you do not see it, you can simply ask him or you can call 1-866-275-2267 or use this web site: www.certified doctor.org

SHOULD I TRY TO FIND A UROLOGIST WHO HAS BEEN IN PRACTICE FOR YEARS OR A NEWLY TRAINED ONE?

Surgery is a skill which can only be mastered with experience. The saying “practice makes perfect” definitely pertains to surgery. Although a urology training program offers the new physician years of training, his surgical skills will continue to improve with further experience. However, each individual physician has his own innate skills. Some more quickly learn and are simply better at the technical craft of surgery than others. For the most part, urologists finishing an accredited urology program have the training and skill set required to care for patients with bladder cancer.

Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected.

Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve.

Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.

WHAT QUALITIES SHOULD MY UROLOGIST HAVE?

Ideally, you should have a competent, technically skilled surgeon who is also approachable and compassionate. You should be able to freely ask questions pertaining to your disease and treatment. Your physician should answer your questions forthrightly. Although some patients prefer a surgeon who will take over all aspects of care with no questions asked, most prefer in depth explanations, especially when alternatives exist and risks are involved.

Your urologist must be an individual who takes your concerns, priorities and values seriously. Your urologist should be a good communicator. It is his responsibility to keep you fully informed of your progress, make you aware immediately if things are not going well, and educate you fully in treatment alternatives. Your specific values should be incorporated into the decision process if alternatives are available. Even if your urologist makes a recommendation and you choose an alternative course (unless you are putting yourself in extreme jeopardy), he should honor your choice and continue his care of you. Becoming an educated patient will make your decision making process easier. Granted, your physician should provide you with the basics, however having time to review and digest the material will allow you to fully understand and accept your treatment regimen, providing you with peace of mind.

Beware of the physician who bombards you with statistics and studies and leaves the decision making to you. After all, you are not a physician and don’t have the practical hands on experience he does. Your physician should provide the facts and the statistics, guide you through the information, and make treatment recommendations based on your preferences.

You may find yourself emotionally distraught and overwhelmed. Having a physician on your side is invaluable. You should be able to trust your physician. Complete honesty on the part of your doctor in his care of you is a must. From the doctor’s point of view, trust is also a necessity. Physicians have an extremely difficult time dealing with individuals who do not trust them. Without trust, the physician patient relationship is extremely hindered.

Lastly, your urologist should be compassionate. Having cancer is tough enough, you shouldn’t have to deal with a rude or arrogant physician. Your urologist should be supportive at all times. He should treat you as an individual and not just as “another cancer patient.” People with bladder cancer will require long term follow up and care. Having a compassionate individual to work with will make a tremendous difference

HOW DO I FIND A GOOD BOARD CERTIFIED UROLOGIST?

A good starting point is your primary care physician. He will generally have a number of specialists to whom he generally refers his urology patients. If the primary care physician has been working with these urologists, he should have an appreciation of their skills and temperament. However, this does not mean he is referring you necessarily to the best available urologist in your area. His choices may be limited by insurance or hospital networks. An excellent source of information would be nurses who work in the operating room, recovery room or on the surgical floor where the urologist does his surgery. Asking friends or other individuals who have had experience with the urologist can also prove useful. After a little digging, you can often quickly learn what type of reputation the urologist has in the community. Generally, if an established urologist has a “good reputation” this is an indication that he has pleased many individuals with his care.

SHOULD I CHECK TO SEE HOW MANY TIMES MY UROLOGIST HAS BEEN SUED?

Given the litigious society we live in, most physicians can face at least one malpractice lawsuit during their careers. In urology, two of the most common causes of litigation would be a surgical mishap leading to a complication, or failure to diagnose cancer in a timely fashion.

Medicine is based on science, but also is an “art.” Individuals do not walk into their physicians offices with a diagnosis and treatment plan always readily apparent. Even the best intentioned, thorough physician will make mistakes. Most of these errors do not result in harm. On occasion they do, and a law suit may follow. If a physician develops a good working relationship with a patient, these bad outcomes more often than not are acknowledged and accepted without legal entanglement. Competent, busy physicians may be dealing with a higher mix of complicated patients, leading to a higher number of potential suits. Physicians who have poor “bed side manner” may find themselves dealing with more suits. If a physician has an inordinate number of suits, “red flags” should go up, as competency may be an issue.

For those individuals who wish to check out the malpractice history of their physician, you may request an inquiry from the National Practitioners Data Bank at: 1-800-767-6732 or check the web site: www.npdb-hipdb.com

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Actos and Bladder Cancer Bulletin

By admin | Published January 25, 2012

Actos and Bladder Cancer : BC is a disease of the environment and age . Populations are increasing in number, and they are growing old as well., . Since more people are living longer, more are at potential risk. Furthermore, the changing environments in developed and developing countries are causing more carcinogen concentration than can be associated to genesis of BC. Several carcinogens have been correlated to BC carcinogenesis.However, it has been proposed that other environmental factors could affect the incidence on urothelial tumors. In fact, as for many other cancers, molecular researchers try to establish genetic alterations linked to carcinogenesis that could justify genetic predisposition.

Cancer is a major public health problem. At the end of the twentieth century, more than 930,000 people died of cancer every year in 15 member countries of the European Union (EU) (Coleman et al. 2003). Using population projections, if the age-specific death rates remain constant, the absolute number of cancer deaths in 2015 will increase to 140,500 (Boyle and Ferlay 2005). BC is a worldwide health problem. In 2006 in Europe, there were an estimated 104,400 incident cases of BC

 

More information on Actos and Bladder Cancer

diagnosed (82,800 in men and 21,600 in women) that represent a 6.6% of the total cancers in men and 2.1% in women. The estimated ratio by gender was 3.8:1, respectively. In men BC was the fourth most common cancer. Bladder cancer repre­sents a 4.1% of total deaths for cancer in men and 1.8% of total deaths in women (Ferlay et al. 2007). In the EU overall (27 countries), BC mortality rates were stable up to early 1990s, and declined, thereafter, by 16% in men and 12% in women, to reach values of 6 and 1.3/100,000, respectively, in the early years of the present decade. The only countries without declining mortality are Croatia and Poland in both sexes, Romania in men, and Denmark in women. This documented and quanti­fied reduction in BC mortality seems related to decrease in tobacco smoking, while its relationship with other risk factors remains controversial (Ferlay et al. 2008).In the United States, it is estimated that about 1.4 million new cases of cancer was diagnosed in 2008. Cancers of the prostate and breast are the most frequently diagnosed cancers in men and women, respectively, followed by lung and colorec­tal cancers in both men and in women. The fourth most common among men is the urinary BC. The 5-year relative survival rate for BC is 81% among whites and 65% among African-Americans (AAs) (taking the normal life expectancy into consider­ation) with an absolute difference of 16%. The survival rates for BC combined with certain site-specific cancer have improved significantly since the 1970s—being 74% during 1975-1977, 78% during 1984-1986, and 81% during 1996-2003.

 

Information from other sources on Actos and Bladder Cancer

Contrary to this data, the prevalence of BC among Native Americans/Alaskan Natives (NA/AN) is generally considered to be low. Despite this low incidence, NA/AN men and women seem to be at relatively greater risk of dying from BC, once it has been diagnosed (Watson and Sidor 2008).Tobacco use is a major preventable cause of death, and especially involved in BC carcinogenesis. The year 2004 marks the anniversary of the release of the first Surgeon General’s report on Tobacco and Health, which initiated a decline in per capita cigarette consumption in the United States (Jemal et al. 2008).

In Egypt, where BC has always been related to bilharziasis, a significance decline of the relative frequency of BC was observed from 27.63% in the old series to 11.7% in the recent series. Bilharzias association dropped from 82.4% to 55.3% and there was a significant increase of transitional cell carcinoma from 16% to 65%, while squamous cell carcinoma was less frequent—from 76% to 28%. Intimately related to this, there was an increase in the median age of patients from 47 to 60 years. The decline in the frequency of BC is related to a decline in bilhar- zias egg positivity in the specimen, and this suggests a better control of the endemic disease in rural population. This trend of less association with bilharzias has changed the clinical and pathological characteristics of BC diagnosed, with signifi­cant predominance of transitional cell carcinoma and an increase in the age of patients, a pattern more similar to that in western series (Gouda et al. 2007).

The incidence and mortality rates associated with BC vary by country, ethnicity, gender, and age. For indeterminate causes, the AAs have only half the risk of white European Americans, but overall, the survival seems to be worse among the primer group. The higher incidence in European Americans is limited to superficial tumors, both groups having a similar risk of invasive tumor (Kirkali et al. 2005).

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Actos and Bladder Cancer Resources

By admin | Published January 25, 2012

Actos and Bladder Cancer: NAVIGATING APPOINTMENTS

Calls initially made to a urology office or clinic are triaged by the scheduling staff who are trained to inquire about the current stage of your workup for your bladder cancer. It is most helpful to have a working knowledge of the tests and diagnoses you have already been given to best facilitate this process. The staff will schedule your initial appoint­ment and mail you all necessary instructions before your appointment. After your initial appointment, subsequent appointments may often be arranged by the individual team members’ staff over the phone. If at the initial ap­pointment it is determined you should have a consultation with another team member (e.g., medical oncologist or radiation oncologist), that appointment is often arranged for you on die day of your initial consultation with the uro- logic oncologist-—-before you leave the clinic if you choose. Therefore having your schedule available allows you to ef­ficiently make these arrangements without conflict.

 

More information on Actos and Bladder Cancer

FINANCIAL IMPLICATIONS OF TREATMENT/INSURANCE CLEARANCE

You probably never planned on getting diagnosed with bladder cancer. There is no convenient time to get this dis­ease, and the diagnosis alone can be difficult to manage. You will need to take time off from work and other duties for your surgery and possibly for other treatment after­ward. It is helpful then to “get your ducks in a row” early on. Finding out how much sick leave you have, short-term disability coverage, copayment information, prescription coverage, and other medical expense issues is helpful to plan for die changes this will have on your budget. Your insurance company may require referrals to be obtained to see certain specialists, to get tests done, to get surgery au­thorized, as well as to obtain other treatments. If you need help with these things, ask for a social worker to assist you. Financial coordinators are available in the clinic. They will work with you to help you navigate the financial aspect of this process.

Some treatments may be recommended that involve par­ticipation in a clinical trial. Usually, a research nurse will as­sist you with navigating the financial aspects of this line of therapy and can provide much of that information for you.

 

Information from other sources on Actos and Bladder Cancer

Financial support services are not well advertised. It re­quires you to take the initiative to ask about them rather than waiting for someone to tell you about them. Be asser­tive and do this for yourself That’s why these programs ex­ist. Money is the primary reason family members get into arguments. Avoid this up front by discussing the issue and planning a budget. Be proactive in asking to meet with the social worker to discuss what support services are available for you as well.

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

Actos and Bladder Cancer

Posted in Uncategorized | Tagged |

Lawsuits Report

By admin | Published January 24, 2012

Lawsuits: Discovery control in complex litigation may take a variety of forms, in­cluding time limits, restrictions on scope and quantity, and sequencing. The Federal Rules and the court’s inherent power provide the court with broad authority. Among other provisions, Federal Rule of Civil Procedure 16(b) di­rects the court to limit the time for discovery, and Rule 26(b) empowers the court to limit the “frequency or extent of use of the discovery methods” under the rules, including the length of depositions. Rule 30(a) imposes a presump­tive limit of ten depositions per side. Rule 30(d) has a presumptive durational limit of one 7-hour day for any deposition. Rule 33 establishes a presumptive limit of twenty-five interrogatories per party (see sections 11.451, 11.462). Rule 26(f)(3) requires the parties to address discovery limits in their proposed dis­covery plan. Propecia Lawsuit

Presumptive limits should be set early in the litigation, before discovery has begun. Information about the litigation will be limited at that time, so lim­its may need to be revised in the light of later developments. But they should be imposed on the basis of the best information available at the time, after full consultation with counsel, and with the understanding that they will remain binding until further order. In determining appropriate limits, the court will need to balance efficiency and economy against the parties’ need to develop an adequate record for summary judgment or trial. This task further underlines the importance of clarifying and understanding the issues in the case before imposing limits.

The discovery plan should include a sched­ule for the completion of specified discovery, affording a basis for ju­dicial monitoring of progress. Setting a discovery cutoff date113 is an important objective, but may not be feasible at the initial conference in complex litigation. The discovery cutoff should not be so far in ad­vance of the anticipated trial date that the product of discovery be­comes stale and the parties’ preparation outdated. Time limits impose valuable discipline on attorneys, forcing them to be selective and helping to move the case expeditiously, but standing alone they may be insufficient to control discovery costs. Unless time limits are com­plemented by other limitations, attorneys may simply conduct multi­track discovery, thereby increasing expense and prejudicing parties with limited resources. To prevent time limits from being frustrated, the judge should rule promptly on disputes so that further discovery is not delayed or hampered while a ruling is pending. Although attorneys will sometimes argue over “priorities,” the rules provide for no such presumptive standing.

For more information on Lawsuits follow us on our RSS Feeds.

Time limits may be complemented by limits on the number and length of depositions, on the number of interrogatories, and on the volume of requests for production. Imposing such limita­tions only after hearing from the attorneys makes possible a reasona­bly informed judgment about the needs of the case. Limitations are best applied sequentially to particular phases of the litigation, rather than as aggregate limitations. When limits are placed on discovery of voluminous transactions or other events, consider using statistical sampling techniques to measure whether the results of the discovery fairly represent what unrestricted discovery would have been expected to produce (section 11.493 discusses statistical sampling). Phased, sequenced, or targeted discovery. Counsel and the judge will rarely be able to determine conclusively early in the litigation what discovery will be necessary; some discovery of potential relevance at the outset may be rendered irrelevant as the litigation proceeds, and the need for other discovery may become known only through later developments. For effective discovery control, initial discovery should focus on matters—witnesses, documents, information. Actos Lawsuit

As the litigation proceeds, this initial discovery may render other discovery unnecessary or provide leads for further necessary dis­covery. Initial discovery may also be targeted at information that might facilitate settlement negotiations or provide the foundation for a dispositive motion; a discovery plan may call for limited discovery to lay the foundation for early settlement discussions. Targeted discovery may be nonexhaustive, conducted to produce critical information rapidly on one or more specific issues. In permitting this kind of dis­covery, it is important to balance the potential savings against the risk of later duplicative discovery should it be necessary to resume the deposition of a witness or the production of documents. Targeted dis­covery may in some cases be appropriate in connection with a motion for class certification; however, matters relevant to such a motion may be so intertwined with the merits that targeting discovery would be in­efficient. Where the scope of the litigation is in doubt at the outset—as, for example, in antitrust litigation—the court should consider limiting discovery to particular time periods or geo­graphical areas, until the relevance of expanded discovery has been established.

Sequencing by parties. Although discovery by all parties ordinarily pro­ceeds concurrently, sometimes one or more parties should be allowed to proceed first. For example, if a party needs discovery to respond to an early summary judgment motion, that party may be given priority. Some judges establish periods in which particular parties have exclu­sive or preferential rights to take depositions, and in multiple litiga­tion, those judges direct that discovery be conducted in some cases before others. Sometimes judges order “common” discovery to pro­ceed in a specified sequence, without similarly limiting “individual” discovery in the various cases.

Information from other sources on Lawsuits

The court may limit the par­ties to supplemental discovery if those materials will be usable as evi­dence in the present litigation. Interrogatory answers, depositions, and testimony given in another action ordinarily are admissible if made by and offered against a party in the current action. Similarly, they may be admissible for certain purposes if made by a witness in the current action.115 Coordination of “common” discovery in related litigation may also save costs, even if the litigation is pending in other courts. If related cases are pending in more than one court, coordinated com­mon discovery can prevent duplication and conflicts. A joint discovery plan can be formulated for all cases, with agreement among parties that one of the cases will be treated as the lead case (with its discovery plan serving as the starting point for development of supplemental plans in the other courts), or with the use of joint deposition notices. See section 20. Counsel may also agree that discovery taken in one proceeding can be used in related proceedings as though taken there.

In multiparty cases with no des­ignated lead counsel, judges sometimes require parties with similar positions to submit a combined set of interrogatories, requests for production, or requests for admission. If voluminous materials are to be produced in response, the responding party may be relieved of the requirement of furnishing copies to each discovering party. Sec­tion 11.44 has further discussion of document discovery, including use of document depositories.

Our use of the term or terms Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Lawsuits visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Mesothelioma Lawsuit Legal News

By admin | Published January 24, 2012

Mesothelioma Lawsuit : A thoracoscopy can provide information crucial for deciding how to treat the patient. It gives great insight. Lastly, if the radiologic tests indicate that there is more solid tumor than fluid, or if there is no longer a space where fluid can accumulate because of previous attempts to control the fluid, an “open” biopsy may be indicated. The incision does not have to be large if the pleura is thickened, but the procedure should be per­formed by a thoracic surgeon who understands the principles of mesothelioma treatment. This surgeon will usually suggest a 3- or 4-inch incision on the side of the chest, overlying an area of pleura that is thickened. The surgeon may or may not remove a small piece of rib at this site to allow a direct view of the thickened pleura. Many times, a good-sized piece of pleura (1 to 1 1/2 inches in diameter) can be removed at this site. Getting a quick freeze of the tis­sue in the operating room, with the pathologist look­ing at the biopsy, will ensure that there’s enough tissue to perform all the required testing and to make a diagnosis. Surgeons performing these biopsies should pick the right place for the biopsy, and the cut (inci­sion) for this biopsy should be in line with the longer incision that would be used later if the patient is a surgical candidate. That way, this shorter incision can be removed.

For more information on Mesothelioma Lawsuit follow us on our RSS Feeds.

Although this operation is performed under general anesthesia (putting the patient to sleep), many times a chest tube to drain the air out of the chest is not needed because the surgeon never enters the chest cav­ity itself. The patient may need some pain medicine for about a week after the procedure if he or she was not having pain before the biopsy. Finally, mesothelioma can “set up shop” and grow tumors at biopsy sites. Radiation therapy is sometimes used after a thoracoscopy or open biopsy to prevent the disease from growing at those sites. If the biopsy results indicate mesothelioma, discuss this option with your physician.

Information from other sources on Mesothelioma Lawsuit

You need to make sure that the diagnosis in your case is correct, and you have every right to ask certain specific questions about the biopsy. Since mesothe­lioma is not a common disease, your primary doctor should make sure that all the appropriate testing has been performed on the specimen, including special stains (those immunos we talked about before), in order to distinguish mesothelioma from other cancers like adenocarcinoma of the lung. If there is any ques­tion, a common practice is to send the slides of the biopsy to specialists in mesothelioma.

It is important that you get the best information avail­able regarding your particular condition in order to decrease confusion, establish confidence in the treat­ment team, and have every opportunity to fight the disease and live as long as possible. In the majority of cases, your physician -will inform you whether the institution he or she is associated with has a special interest in the disease and treats more than 50 cases of mesothelioma per year. If those resources are not at your physician’s disposal, he or she should recommend a second opinion at a cancer center, which is a spe­cialized institution to which he can refer you for mesothelioma. You should not lose your primary physician or the physician who made this initial diag­nosis as your advocates.

Our use of the term or terms Mesothelioma Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Lawsuit visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Actos and Bladder Cancer Action

By admin | Published January 24, 2012

Actos and Bladder Cancer : An intravenous pyelogram (IVP) is an X-ray study that shows the general outline of the kidneys and better detail of the collecting system than an ultra­sound. X-ray contrast is given to the patient intra­venously. The kidneys then filter and concentrate the contrast, creating an image on an X-ray taken a few minutes after the injection is given. A small tumor or stone inside the collecting system can be seen as a dark spot inside the collecting system. Historically, the IVP was a common test to evaluate upper tracts. However, due to the decreased cost of CT scans and the increased availability, it has largely been replaced by CT scanning.

CT scanners use X-rays to create a detailed image of the internal organs. The scanner takes many X-rays at once and uses a computer to combine all of the images into the one picture that you see. When getting a CT scan of the kidneys, the patient is usually scanned three times. The first scan is per­formed without contrast and will reveal any kidney stones. The second scan is performed with contrast, which helps to show tumors in the kidneys. The third scan is obtained a few minutes later, after the kidney has had time to process the contrast. The contrast fills the collecting system similar to the IVP but with greater detail. A CT scan is very good for seeing tumors in both the kidneys and the col­lecting system. In addition to the ability to see the kidneys and ureters better, the CT scan allows for visualization of the entire abdomen and lymph nodes, helping to identify metastases or unrelated diseases. Over the last several years, the cost of CT scans has come down, and the availability of scan­ners to patients has increased, making the CT scan the most common upper tract study. As with the IVP test, CT scans meant to examine the kidneys

For more information on Actos and Bladder Cancer follow us on our RSS Feeds.

Although ureteroscopy is not technically an “upper tract study,” it gives us the most definitive examina­tion. It is similar to cystoscopy but uses a smaller scope. In the operating room or well-equipped office, the ureteroscope is carefully passed into the ureter as it opens into the bladder. This allows the urologist to see the inside of the ureter. It is gently passed all of the way up the ureter into the kidney. Like cys­toscopy, there are both rigid and flexible uretero- scopes. The flexible scope allows doctors to see all or most of the deep corners of the collecting system within the kidney. Biopsies of any suspicious areas can be taken and sent to pathology for analysis. Although ureteroscopy provides the best view of the collecting system, it usually requires anesthesia, and there is some small risk of damage to the kidney or ureter; thus, it is usually reserved for those patients who have had an abnormal upper tract study.

Information from other sources on Actos and Bladder Cancer

Cysview (hexaminolevulinate hydrochloride, GE health­care) has recently been approved as an optical imaging agent for use in the cystoscopic detection of non-muscle invasive papillary bladder cancer among patients sus­pected or known to have lesion(s) on the basis of prior cystoscopy. When used in combination with blue light (fluorescence) cystoscopy (Karl Storz D-Light C Pho­todynamic Diagnostic [PPD] system) it identified at least 1 more noninvasive papillary bladder tumor than rou­tine cystoscopy in about one third of the patients with such tumors. It is also useful in detecting carcinoma in situ, identifying 28% more patients with carcinoma in situ than standard cystoscopy.

Urine cytology is commonly used to screen for bladder cancer in patients who have hematuria as well as to monitor for recurrences in patients who are being treated for bladder cancer. Overall, urine cytology is able to detect 40% to 60% of bladder cancers, but the ability of cytology to detect a tumor varies depending on the grade, stage, and location of the tumor. In low-grade, low- stage tumors, cytology will detect only 25% to 40% of the tumors. It will perform better as the grade and stage of the tumor increase, with the best detection rate being for carcinoma in situ. Cytology detects approximately 90% of cases of carcinoma in situ.

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |

Multaq Lawyer Information

By admin | Published January 24, 2012

Multaq Lawyer: The first hepatitis virus to be discovered, hepatitis B (HBV), has infected an estimated 2 billion people worldwide. About 300 million are chronic carriers of the virus, including about 1.25 million Americans. HBV can be deadly; its complications kill about 1 million people every year, and it is the most prevalent cause of cirrhosis and liver cancer in the world, particularly in Africa and Southeast Asia. Yet most people infected with HBV lead fully normal lives.

For more information on Multaq Lawyer follow us on our RSS Feeds.

The HBV virus can be found in body fluids, including saliva, blood, tears, and breast milk, though it is transferred between people only through blood and semen. Casual contact, such as hugging or shaking hands, does not spread the disease; in fact, not everyone infected with HBV is contagious. HBV can be con­tracted only through sexual contact, a blood exchange, or from a pregnant mother to her fetus—a method of transmission common in Africa and Asia.

Before 1975, blood and platelets collected from blood donors (during blood drives, for example) were not screened for HBV so transfusions once accounted for many HBV infections in this country. Today, donated blood is tested for HBV, but the virus continues to be transferred through more subtle blood exchanges, such as when an infected person shares a razor or nail clippers, or exposes another person through a bleeding skin condition.

Information from other sources on Multaq Lawyer

Needles used for tattooing and acupuncture can also be contaminated with blood infected with HBV. People diagnosed with hepatitis B need to take special care to cover any bleeding spots, and everyone should avoid contact with used needles. The HBV virus can live on an open surface, including needles, for up to a week. In the United States, HBV is most often transmitted through sexual contact with an HBV carrier.

Immunization is key to preventing hepatitis B. People who have been vaccinated are virtually 100 percent protected, so HBV is a disease that could be eliminated. For now, though, its important for individuals at risk to take precautions. Health-care workers, any­one who received a blood transfusion before 1975, and anyone who lives with (or is sexually intimate with) an HBV-infected person are candidates for screening. In fact, it is recommended that sexually active homosexual men, intravenous drug users, dialysis patients, and anyone who has more than one sex partner within six months be screened for HBV. Anyone who receives results that indicate he or she is not immune should receive the vaccine series.


Our use of the term or terms Multaq Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawyer visit our site often.

http://www.seedol.com

Posted in Uncategorized | Tagged |